Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia.
Krystal
John H
JH
Anand
Amit
A
Moghaddam
Bita
B
D000818:Animals; D004298:Dopamine / Q000502:physiology; D005971:Glutamates / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D007649:Ketamine / Q000494:pharmacology; D000077213:Lamotrigine; D023421:Models, Animal; D010622:Phencyclidine / Q000494:pharmacology; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors* / Q000502:physiology*; D012559:Schizophrenia / Q000378:metabolism / Q000503:physiopathology*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology; D014227:Triazines / Q000494:pharmacology
D005971:Glutamates; D016194:Receptors, N-Methyl-D-Aspartate; D014227:Triazines; D007649:Ketamine; D010622:Phencyclidine; D000077213:Lamotrigine; D004298:Dopamine